LEVARE® Could Potentially Help
To Mitigate COVID-19
COVID-19 has been associated with several physiologic symptoms. One in particular has been referred to as a cytokine storm. It has been suggested that this emanates from our body having an excessive immune response to the SARS-CoV2 virus, leading to an extensive release of cytokines that cause a massive inflammatory response in the lungs often necessitating prolonged mechanical ventilation and in some cases COVID long-hauler syndrome.
LEVARE is comprised of several ingredients that are well know for their anti-inflammatory characteristics as well as their ability to inhibit or reduce the effects of certain cytokines and mediators of inflammation and pain, several which are associated with the cytokine storm seen in COVOD-19 and COVID long-hauler syndrome e.g. TNF, IL-1 and 6 etc. to name a few. LEVARE, therefore, represents a potential natural formulation that could help mitigate the cytokine storm and COVID long-hauler syndrome associated with SARS-CoV2 infection and potentially reduce morbidity and mortality as well as costs both human and fiscal.
